Welcome.
Post-doctoral research fellow, 2007-present
Division of Gastroenterology and Hepatology
Stanford University's School of Medicine
PI: Jeffrey Glenn, Ph.D., M.D., Director, Center of Hepatitis and Liver Tissue Engineering
Ph.D. in Chemical Engineering, 2003-2006
M.S. in Material Science and Engineering, 2001-2003
Stanford University
Advisor: Curtis W. Frank, Ph.D., Director, Center for Polymer Interfaces and Macromolecular Assemblies; Senior Associate Dean, Faculty Affairs
My CV in PDF
Post-doctoral research fellow, 2007-present
Division of Gastroenterology and Hepatology
Stanford University's School of Medicine
PI: Jeffrey Glenn, Ph.D., M.D., Director, Center of Hepatitis and Liver Tissue Engineering
Ph.D. in Chemical Engineering, 2003-2006
M.S. in Material Science and Engineering, 2001-2003
Stanford University
Advisor: Curtis W. Frank, Ph.D., Director, Center for Polymer Interfaces and Macromolecular Assemblies; Senior Associate Dean, Faculty Affairs
My CV in PDF
News update!
Nam-Joon
Cho's
My paper on
a novel class of HCV inhibitors was accepted in Science Translational
Medicine in January 2010.
Articles highlighting this work as of January 25th, 2010:
Reuters, Team finds potential path for Hepatitis C drugs
CNBC, Team finds potential path for Hepatitis C drugs
BusinessWeek, New treatment eyed for Hepatitis C
Agence France Presse, New research finds promising treatment for hepatitis C
ScienceDaily, Potential new class of drugs to combat Hepatitis C identified
EurekAlert, Potential new class of drugs to combat Hepatitis C identified
The Independent (UK), New research finds promising treatment for hepatitis C
Yahoo News, Team finds potential path for Hepatitis C drugs
MSN Health, New treatment eyed for Hepatitis C
Health Day News, New treatment eyed for Hepatitis C
eScience News, Potential new class of drugs to combat hepatitis C identified by Stanford scientists
Inside Stanford Medicine, Potential new class of drugs to combat Hepatitis C identified by scientists, (Stanford University Cover)
BusinessWire, Potential new class of drugs to combat Hepatitis C identified by Stanford scientists,
Sharp, New Treatment Eyed for Hepatitis,
the Malay Mail, Scientists close in on hepatitis C vaccine
Topnews, Potential New Path for Hepatitis C Medicines Discovered by Scientists
San Francisco Business Times, Eiger IDs new class of hep C inhibitors
eBioNews, Potential New Class of Drugs to Combat Hepatitis C Identified
My paper on the mechanism of an antiviral peptide's mode of action is featured in ACS Chemical Biology in December, 2009.
My paper on combined QCM-D and reflectometry measurements to understand biomacromolecular interactions is featured in Analytical Chemistry in May, 2009.
Dr. Kanazawa and I presented a review article on QCM-D principles and biological applications in the Journal of Sensors in April, 2009.
My paper on liver tissue engineering was featured on the cover of Biomedical Materials in February, 2009.
Articles highlighting this work as of January 25th, 2010:
Reuters, Team finds potential path for Hepatitis C drugs
CNBC, Team finds potential path for Hepatitis C drugs
BusinessWeek, New treatment eyed for Hepatitis C
Agence France Presse, New research finds promising treatment for hepatitis C
ScienceDaily, Potential new class of drugs to combat Hepatitis C identified
EurekAlert, Potential new class of drugs to combat Hepatitis C identified
The Independent (UK), New research finds promising treatment for hepatitis C
Yahoo News, Team finds potential path for Hepatitis C drugs
MSN Health, New treatment eyed for Hepatitis C
Health Day News, New treatment eyed for Hepatitis C
eScience News, Potential new class of drugs to combat hepatitis C identified by Stanford scientists
Inside Stanford Medicine, Potential new class of drugs to combat Hepatitis C identified by scientists, (Stanford University Cover)
BusinessWire, Potential new class of drugs to combat Hepatitis C identified by Stanford scientists,
Sharp, New Treatment Eyed for Hepatitis,
the Malay Mail, Scientists close in on hepatitis C vaccine
Topnews, Potential New Path for Hepatitis C Medicines Discovered by Scientists
San Francisco Business Times, Eiger IDs new class of hep C inhibitors
eBioNews, Potential New Class of Drugs to Combat Hepatitis C Identified
My paper on the mechanism of an antiviral peptide's mode of action is featured in ACS Chemical Biology in December, 2009.
My paper on combined QCM-D and reflectometry measurements to understand biomacromolecular interactions is featured in Analytical Chemistry in May, 2009.
Dr. Kanazawa and I presented a review article on QCM-D principles and biological applications in the Journal of Sensors in April, 2009.
My paper on liver tissue engineering was featured on the cover of Biomedical Materials in February, 2009.
Featured
in Biomedical Materials in February, 2009.
Featured
in Analytical Chemistry in May, 2009.
Other
updates
Science
Translational Medicine: Three-dimensional rendering of vesicle aggregation
induced by an amphipathic, alpha helical peptide derived from the hepatitis C
virus NS4B protein, as imaged by atomic force microscopy. light brown
corresponds to vesicle aggregates.